HNN3.0
Register
Register
Register

Project cooperationUpdated on 13 May 2026

Clinical R&D services

Business Development Director at Pharmahungary Group

Budapest, Hungary

About

Clinical R&D services focusing on clinical trials with medical devices, In Vitro Diagnostics, combination products, and drugs including small molecules as well as biologics and Advanced Therapy Medicinal Products (ATMPs). Expertise includes managing Investigator Initiated Trials, and niche trials that need strong scientific and regulatory support due to e.g. sensitive patient population.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
  • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies

Similar opportunities

  • Project cooperation

    Advancing Clinical Excellence and European Collaboration: Kaunas Hospital at the Heart of Innovation and Care

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Andrius Ališauskas

    MD, PhD, Head of Research and Study Department at LSMU Kaunas Hospital at Kaunas Hospital of Lithuanian University of Health Sciences

    Kaunas, Lithuania

  • Project cooperation

    Women Health

    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Monika Ślęzak

    Coordinator of Industry Contact Point Medical Technologies and Health at Łukasiewicz Research Network - PORT Polish Center for Technology Development

    Wroclaw, Poland

  • Project cooperation

    Intrinsic nanomedicine and sex/gender mechanisms in cardiovascular disease

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Camelia Gentiana Ciubuc (Jurj)

    PhD Candidate/ Medical Doctor at West University “Vasile Goldiș” of Arad

    Iasi, Romania